News | March 10, 2008

MITA Thanks Congress for CCTA Coverage Plea to CMS

March 10, 2008 – The Medical Imaging & Technology Alliance (MITA), a division of NEMA, today praised the 88 Members of Congress who urged the Centers for Medicare & Medicaid Services (CMS) to reconsider its proposed national coverage decision (NCD) that will limit patient access to cardiac computed tomography angiography (CCTA).

Representatives Baldwin, Buyer, Camp, Cramer, Green (Gene), McCarthy (Carolyn), Myrick, Pitts, Walsh, Whitfield, Wilson (Heather) and Senators Shelby and Voinovich wrote individual letters to CMS.
After weighing-in individually, Reps. McCarthy, Pitts and Green also coordinated a Dear Colleague letter to CMS. This move garnered signatures from 78 Members of Congress, including:

Alexander, Allen, Berman, Bilirakis, Blackburn, Boswell, Boustany, Butterfield, Capps, Capuano, Castle, Conaway, Cubin, Cummings, Delahunt, English, Ferguson, Fossella, Frank, Gerlach, Gilchrest, Gonzalez, Green (Al), Green (Gene), Hall (Ralph), Herger, Higgins, Hodes, Hulshof, Inglis, Inslee, Jefferson, Kagen King (Peter), Kirk, Kuhl, Larsen, LaTourette, LoBiondo, Lowey, Maloney, Marchant, Matheson McCarthy (Carolyn), McCarthy (Kevin), McGovern, McNulty, Meek, Michaud, Moore (Dennis), Murphy (Christopher), Neal, Neugebauer, Olver, Ortiz, Pascrell, Paul, Pickering, Pitts, Porter, Price, (Tom), Rahall, Reyes, Rogers (Mike-MI), Roskam, Ruppersberger, Scott (Bobby), Sessions, Shimkus, Souder, Sutton, Tanner, Tierney, Towns, Tsongas, Walberg, Wamp, and Wilson (Charles).

“CCTA is an extremely important medical imaging tool that detects Coronary Artery Disease (CAD) within seconds, eliminating the need for surgery or catheterization,” said Andrew Whitman, Vice President, MITA. “MITA applauds the Members of Congress who recognize that CCTA has revolutionized the way doctors diagnose heart disease and who are questioning CMS’ proposed decision to eliminate CCTA coverage.”

According to the National Institutes of Health, CAD is the most common type of heart disease—and the number one killer for both men and women. Based on existing evidence and clinical analysis, CCTA has widespread acceptance as a proven technology that rules out heart disease with greater than 99 percent accuracy, while avoiding the high costs of more invasive and expensive procedures. As a result, CCTA is used in more than 2,000 centers nationwide and has been approved by local Medicare carriers in all 50 states.

“CCTA has become the standard of care for cardiac disease throughout the country and the world,” said Whitman. “MITA is proud to work with Members of Congress and others to ensure that patients have coverage for this important test. It is our hope that CMS will permit continued access to this state-of-the-art diagnostic tool for heart disease patients nationwide.”

For more information: www.medicalimaging.org

Related Content

HeartFlow Analysis Successfully Stratifies Heart Disease Patients at One Year
News | CT Angiography (CTA) | March 19, 2019
Late-breaking results confirm the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis enables...
Aidoc Announces CE Mark for AI-based Pulmonary Embolism Workflow Tool
News | Computed Tomography (CT) | March 04, 2019
Artificial intelligence (AI) radiology solution provider Aidoc announced the commercial release of its CE-marked...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
CT Offers Non-Invasive Alternative for Complex Coronary Disease Treatment Planning
News | CT Angiography (CTA) | October 16, 2018
A new study published in the European Heart Journal shows computed tomography (CT) can be a useful aid in heart team...

Image courtesy of Siemens Healthineers

Feature | CT Angiography (CTA) | September 06, 2018 | Dave Fornell
There have been a few big, recent advancements in cardiac computed tomography angiography (CCTA) imaging technology....
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Neuro Imaging | August 27, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...
Videos | Computed Tomography (CT) | July 25, 2018
A discussion with Patricia Dickson, LRT(CT), director of imaging and outpatient services, Capital Cardiology Associat
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...